Lena F. Schimke

Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome

Ellen D. Renner, Stacey Rylaarsdam, Stephanie Añover-Sombke et al. · Journal of Allergy and Clinical Immunology · 2008 · 339 citations · Full text

Life Sciences, Genetics, Immunology +15

Diagnostic approach to the hyper-IgE syndromes: Immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis

Lena F. Schimke, Julie Sawalle‐Belohradsky, Joachim Roesler et al. · Journal of Allergy and Clinical Immunology · 2010 · 169 citations · Full text

Life Sciences, Dermatology, Immunology +17

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis

Otávio Cabral-Marques, Alexandre H. C. Marques, Lasse M. Giil et al. · Nature Communications · 2018 · 169 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity

Otávio Cabral-Marques, Gilad Halpert, Lena F. Schimke et al. · Nature Communications · 2022 · 147 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

First Report of the Hyper-IgM Syndrome Registry of the Latin American Society for Immunodeficiencies: Novel Mutations, Unique Infections, and Outcomes

Otávio Cabral-Marques, Stefanie Klaver, Lena F. Schimke et al. · Journal of Clinical Immunology · 2014 · 83 citations · Full text

Life Sciences, Immunology, Internal Medicine +17